Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-4
|
pubmed:dateCreated |
1994-5-27
|
pubmed:abstractText |
Defects in T cell function are known to be present in a subset of patients with CVID, but the true nature of these defects still has to be revealed. In prior studies we described that T cells from these patients show an impaired proliferative response following activation with recall antigens (E. coli, Tet. Tox., TBE and PPD). Gene expression of IL2 and IFN-gamma in patients' T cells following antigenic stimulation was significantly reduced compared to controls, while IL-2R transcripts were normal. To further characterize the defect we examined T cell responses to bacterial enterotoxins, collectively termed superantigens. Following stimulation with optimal (10 ng/ml p < 0.05) as well as suboptimal (1 ng/ml p < 0.0025) concentrations of staphylococcal enterotoxin A (SEA), proliferative response and cytokine release (IL-2 and IFNg) were significantly decreased in patients' T cells as compared to controls'. When patients' T cells were stimulated with staph. enterotox. C3 (SEC3) an even more pronounced difference between patients' and controls' T cells could be observed (10 ng/ml p < 0.002, 1 ng/ml p < 0.0005). Our data indicate that, in addition to the defect in antigen-induced T cell activation, T cells of CVID patients express a broader impairment in the interaction between the antigen presenting cell and the TCR.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD3,
http://linkedlifedata.com/resource/pubmed/chemical/Enterotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell,
http://linkedlifedata.com/resource/pubmed/chemical/Superantigens
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1067-795X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
15-6
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:8167691-Antigens,
pubmed-meshheading:8167691-Antigens, CD3,
pubmed-meshheading:8167691-Common Variable Immunodeficiency,
pubmed-meshheading:8167691-Enterotoxins,
pubmed-meshheading:8167691-Humans,
pubmed-meshheading:8167691-Interferon-gamma,
pubmed-meshheading:8167691-Interleukin-2,
pubmed-meshheading:8167691-Lymphocyte Activation,
pubmed-meshheading:8167691-Receptors, Antigen, T-Cell,
pubmed-meshheading:8167691-Staphylococcus aureus,
pubmed-meshheading:8167691-Superantigens,
pubmed-meshheading:8167691-T-Lymphocytes
|
pubmed:year |
1993
|
pubmed:articleTitle |
Activation of CVID patients' T cells with conventional antigens and superantigens.
|
pubmed:affiliation |
Institute of Immunology, University of Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
In Vitro
|